CoChat

A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters

Hahn, Maureen K., Robertson, David, Blakely, Randy D. · 2003 · The Journal of Neuroscience
Cited by 107

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The norepinephrine transporter (NET) mediates reuptake of norepinephrine released from neurons, and, as such, it is an important regulator of noradrenergic neurotransmission. Recently, our laboratory reported a polymorphism in the human NET (hNET) gene A457P in an individual with the autonomic disorder orthostatic intolerance (OI). The presence of the hNET-A457P allele tracked with elevated heart rates and plasma NE levels in family members. hNET-A457P lacks >98% transport activity in several heterologous expression systems. In the present work, Western blot and biotinylation analyses performed in transiently transfected COS-7 cells revealed impairment in processing of hNET-A457P to the fully glycosylated form and a decrease in surface expression to ∼30% of hNET-wild type (hNET-wt). Because the hNET-A457P mutation is carried on a single allele in OI subjects, we examined the influence of cotransfection of hNET-wt and hNET-A457P and found that hNET-A457P exerts a dominant-negative effect on hNET-wt uptake activity. Experiments to determine oligomerization as a potential mechanism of the dominant-negative effect demonstrated that hNET-A457P coimmunoprecipitates with, and diminishes surface expression of, hNET-wt. These results reveal that hNET-A457P causes a conformational disruption that interferes with transporter biosynthetic progression and trafficking of both the mutant transporter and hNET-wt. These results elucidate a molecular mechanism for the disrupted NE homeostasis and cardiovascular function evident in OI patients with the hNET-A457P mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.23-11-04470.2003

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. 10.1124/mol.59.3.514 · DOI
  2. 1998, J Pharmacol Exp Ther, 287, 733, 10.1016/S0022-3565(24)37851-6 · DOI · Paper page
  3. 1998, J Pharmacol Exp Ther, 287, 744, 10.1016/S0022-3565(24)37852-8 · DOI · Paper page
  4. 10.1006/jmcc.2000.1319 · DOI
  5. 10.1523/JNEUROSCI.19-12-04705.1999 · DOI · Paper page
  6. 10.1016/S0003-9861(02)00232-1 · DOI
  7. 2001, J Neurosci, 21, 8319, 10.1523/JNEUROSCI.21-21-08319.2001 · DOI · Paper page
  8. 10.1016/0735-1097(94)00353-R · DOI · Paper page
  9. 1998, Hypertension, 32, 831, 10.1161/01.HYP.32.5.831 · DOI
  10. 1993, Hum Genet, 91, 278
  11. 1995, Mol Pharmacol, 48, 1030, 10.1016/S0026-895X(25)10570-1 · doi:10.1016/s0026-895x(25)10570-1
  12. 10.1523/JNEUROSCI.18-19-07739.1998 · DOI
  13. 10.1006/bbrc.1998.9158 · doi:10.1006/bbrc.1998.9158
  14. 10.1074/jbc.272.45.28321 · DOI · Paper page
  15. 1999, J Pharmacol Exp Ther, 289, 877, 10.1016/S0022-3565(24)38214-X · DOI · Paper page
  16. 10.1073/pnas.97.15.8641 · DOI · Paper page
  17. 1983, Physiol Rev, 63, 845
  18. 10.1111/j.1469-7793.2001.0479c.xd · DOI
  19. 1995, J Exp Biol, 198, 2197, 10.1242/jeb.198.10.2197 · DOI · Paper page
  20. 1994, J Biol Chem, 269, 15985, 10.1016/S0021-9258(17)33961-3 · DOI · Paper page
  21. 10.1074/jbc.274.33.23020 · doi:10.1074/jbc.274.33.23020
  22. 1994, J Biol Chem, 269, 7124, 10.1016/S0021-9258(17)37256-3 · DOI · Paper page
  23. Hahn MK, Blakely RD ( 2002a) Gene organization and polymorphisms of monoamine transporters. relationship to psychiatric and other complex diseases. In: Neurotransmitter transporters. Structure, function, and regulation (Reith MEA, ed), pp 111–169. Totowa, NJ: Humana. · DOI
  24. 10.1038/sj.tpj.6500106 · DOI
  25. 10.1073/pnas.181344298 · DOI · Paper page
  26. 1961, Br J Pharmacol, 21, 523
  27. 10.1021/bi00096a030 · DOI
  28. 10.1073/pnas.060408997 · DOI · Paper page
  29. 10.1074/jbc.274.16.10731 · DOI
  30. 10.1038/227680a0 · DOI · Paper page
  31. 1997, J Psychopharmacol, 11, S39
  32. 10.1523/JNEUROSCI.14-08-04903.1994 · DOI · Paper page
  33. 10.1016/S0896-6273(00)00012-X · DOI · Paper page
  34. 1994, J Biol Chem, 269, 12290, 10.1016/S0021-9258(17)32714-X · DOI · Paper page
  35. 1996, Mol Pharmacol, 50, 266, 10.1016/S0026-895X(25)09218-1 · DOI · Paper page
  36. 1992, J Cardiovasc Pharmacol, 19, 10, 10.1097/00005344-199201000-00002 · DOI
  37. 10.1046/j.1471-4159.1994.63030917.x · DOI
  38. 10.1172/JCI8688 · DOI · Paper page
  39. 10.1097/00008571-200203000-00010 · DOI
  40. 10.1074/jbc.M110783200 · DOI
  41. 10.1016/0024-3205(90)90132-B · DOI · Paper page
  42. 10.1038/sj.bjp.0702926 · DOI · Paper page
  43. 10.1176/appi.ajp.122.5.509 · doi:10.1176/appi.ajp.122.5.509
  44. 10.1074/jbc.M007357200 · DOI · Paper page
  45. 10.2337/diab.45.6.801 · DOI · Paper page
  46. 10.1074/jbc.M205602200 · DOI · Paper page
  47. 10.1161/01.RES.55.5.689 · DOI · Paper page
  48. 1989, Naunyn Schmiedebergs Arch Pharmacol, 340, 502
  49. 10.1093/eurheartj/12.suppl_F.38 · DOI
  50. 10.1006/mcne.1997.0619 · DOI
  51. 10.1002/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3 · DOI · Paper page
  52. 10.1074/jbc.274.51.36058 · DOI
  53. 10.1523/JNEUROSCI.23-05-01697.2003 · DOI · Paper page
  54. 1992, J Pharmacol Exp Ther, 260, 427, 10.1016/S0022-3565(25)11249-4 · DOI · Paper page
  55. 10.1074/jbc.M201926200 · DOI · Paper page
  56. 1978, Eur J Pharmacol, 51, 193, 10.1016/0014-2999(78)90404-1 · doi:10.1016/0014-2999(78)90404-1
  57. 10.1038/74839 · DOI · Paper page
  58. 10.1074/jbc.274.44.31123 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Hahn, M. K., Robertson, D., & Blakely, R. D.
Venue
The Journal of Neuroscience
Published
2003-06-01
Volume
23
Issue
11
Pages
4470-4478
ISSN
  • 0270-6474
  • 1529-2401
Cited by
107
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.